The National Institute of Statistical Science (NISS) and Merck are sponsoring a Virtual Meet-Up on Adaptive Trials for Drug Development.
Adaptive clinical trials use accruing data to make changes in the ongoing trial. Changes based on early information can increase efficiency, by limiting resources to likely failures and increasing them for promising interventions. Such changes are also likely to be beneficial from the patients’ perspective. Although adaptive trials have been part of drug development for about 30 years, there is still some confusion over the best ways to utilize them. In this meet-up we will discuss some of the guidelines for adaptive trials and explore some of the ways they are being used effectively today.
Agenda
The agenda for the meet-up is as follows:
Vladimir Dragalin, (Janssen)
"Thoughts on ICH E20 EWG on Adaptive Clinical Trials"
QiQi Deng, (Boehringer-Ingelheim)
"Two stage adaptive design in dose ranging studies and the alternatives"
Scott Berry, (Berry Consultants)
"Master protocols & platform trials"
NISS-Merck Webinar Settings - Now Using Zoom!
Zoom users will be prompted to download and run a small Zoom meeting launcher. (View a 53 sec video - "How to Join a Meeting")
Registered attendees are view-only participants.
Use the Question & Answer (Q&A) feature to ask questions during the meet-up.
Click on the Q&A icon at the bottom of the Zoom window, type in your question for the panelist and click ‘Enter’.
When a speaker is sharing his/her screen you can minimize the video displays of the other speakers by clicking on the dash button that appears on top of the panel showing all of the speakers.
Event Type
- NISS Hosted
- NISS Sponsored
Host
Sponsor
Cost
Website
Location
Policy
